Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B A G Haanen

Showing results (1-10 of 242) with videos related to

Pageof 25
Sort By:
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Immunotherapy of melanomaJohn B A G Haanen
Cell|September 9, 2017
Converting Cold into Hot Tumors by Combining ImmunotherapiesJohn B A G Haanen
ESMO Open|July 19, 2018
Questions asked in the everyday practice: immune checkpoint inhibitorsJohn B A G Haanen
Progress in Tumor Research|September 19, 2015
Immune Checkpoint InhibitorsJohn B A G Haanen, Caroline Robert
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2017
Pembrolizumab in Small-Cell Lung Cancer: In Search of the Best BiomarkerEgbert F Smit, John B A G Haanen
Current Opinion in Oncology|January 6, 2023
Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for patients with solid cancersLiselotte Tas, Inge Jedema, John B A G Haanen
Nature Medicine|March 8, 2007
Vaccine leads to memory lossJohn B A G Haanen, Ton N M Schumacher
Hematology/Oncology Clinics of North America|March 24, 2021
Cellular Therapy and Cytokine Treatments for MelanomaJessica S W Borgers, John B A G Haanen
Cancer Journal (Sudbury, Mass.)|March 25, 2024
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic MelanomaChristy Los, Sebastian Klobuch, John B A G Haanen
The New England Journal of Medicine|March 1, 2023
Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma. ReplyMaartje W Rohaan, Rob Kessels, John B A G Haanen
Pageof 25

Showing results (1-10 of 242) with videos related to

Sort By:
Pageof 25
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Immunotherapy of melanomaJohn B A G Haanen
Cell|September 9, 2017
Converting Cold into Hot Tumors by Combining ImmunotherapiesJohn B A G Haanen
ESMO Open|July 19, 2018
Questions asked in the everyday practice: immune checkpoint inhibitorsJohn B A G Haanen
Progress in Tumor Research|September 19, 2015
Immune Checkpoint InhibitorsJohn B A G Haanen, Caroline Robert
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2017
Pembrolizumab in Small-Cell Lung Cancer: In Search of the Best BiomarkerEgbert F Smit, John B A G Haanen
Current Opinion in Oncology|January 6, 2023
Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for patients with solid cancersLiselotte Tas, Inge Jedema, John B A G Haanen
Nature Medicine|March 8, 2007
Vaccine leads to memory lossJohn B A G Haanen, Ton N M Schumacher
Hematology/Oncology Clinics of North America|March 24, 2021
Cellular Therapy and Cytokine Treatments for MelanomaJessica S W Borgers, John B A G Haanen
Cancer Journal (Sudbury, Mass.)|March 25, 2024
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic MelanomaChristy Los, Sebastian Klobuch, John B A G Haanen
The New England Journal of Medicine|March 1, 2023
Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma. ReplyMaartje W Rohaan, Rob Kessels, John B A G Haanen
Pageof 25